BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Dalton Pharma Services and X-GEN Pharmaceuticals, Inc. Enter into a Manufacturing Services Agreement


6/14/2007 11:23:05 AM

TORONTO, June 14 /PRNewswire/ - Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced the company has entered into a long term Manufacturing Services Agreement with X-GEN Pharmaceuticals, Inc., a specialty pharma company based in Big Flats, New York, focused on providing quality therapeutic options in both specialized disease areas and broad range treatment choices.

Dalton Pharma Services has been contracted to fill/finish under cGMP, sterile commercial products for X-GEN. The two companies, aligned in core values and business practices are tactically poised for growth in the area of sterile injectables.

"Our Establishment License from Health Canada, combined with our expert capabilities in analytical services and sterile manufacturing capacity, solidified the manufacturing agreement," said Peter Pekos, President and CEO. "This agreement validates Dalton's customer oriented approach to bringing our clients' products to the market quickly. We are extremely pleased to be working with X-GEN Pharmaceuticals, and look forward to providing further commercial manufacturing services for X-GEN, a strategic partner for Dalton," continued Pekos.

Susan Badia, President and Chief Executive Officer of X-GEN remarked, "The partnership with Dalton is an example of X-GEN's commitment to expanding our offering of pharmaceutical products which benefit the healthcare community as reliable, cost-effective treatment choices. We are excited about the opportunity to partner with a company whose client focus and commitment to quality match our own. Sharing these values with partners like Dalton is vital to our ability to provide products which fulfill the therapeutic needs of physicians and their patients."

About Dalton Pharma Services

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved, contract pharmaceutical manufacturer that supplies chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of medicinal chemistry, fine chemical manufacture, custom peptides and antisense oligo production. Dalton provides cGMP manufacturing and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton can produce active pharmaceutical ingredients (API), at the gram or kilogram scale. Dalton can carry out sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition to drug testing, Dalton's analytical chemistry laboratory offers method development, validation, ICH stability programs and HPLC-MS services to its clients.

About X-Gen Pharmaceuticals Inc.

X-GEN Pharmaceuticals, Inc. is a generic drug company specializing in the manufacturing and distribution of mature anti-infective pharmaceutical products. X-GEN's strategic focus is on the continuous development of quality generic pharmaceuticals which enhance patient care as reliable and affordable treatment options. X-GEN's product offering includes a broad range of dosage forms, including injectables, topical solutions, oral solutions, oral solids, powders for prescription compounding and inhalants.

Dalton Pharma Services

CONTACT: Peter Pekos, Dalton Pharma Services, Tel: (416) 661-2102, Fax:(416) 661-2108, ppekos@dalton.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->